Literature DB >> 17116037

Differential effects of antiepileptic drugs on neuroactive steroids in men with epilepsy.

Andrew G Herzog1, Frank W Drislane, Donald L Schomer, Page B Pennell, Edward B Bromfield, Barbara A Dworetzky, Erin L Farina, Cheryl A Frye.   

Abstract

PURPOSE: To compare serum levels of neuroactive steroids among men with epilepsy who take various antiepileptic drugs, untreated men with epilepsy and normal controls (NC).
METHODS: Subjects were 85 men with localization-related epilepsy [unmedicated >6 months (No Rx)-10, carbamazepine (CBZ)-25, phenytoin (PHT)-25, lamotrigine (LTG)-25] and 25 NC. Sexual function scores (S-Score), hormone levels [dehydroepiandrosterone sulfate (DHEAS), bioactive (BA) testosterone (T), estradiol (BAE), and androstanediol (BAL)] and the ratios of inhibitory to excitatory neuroactive metabolites of T, i.e., BAL/BAE, were compared among groups.
RESULTS: S-scores, DHEAS, and bioactive testosterone (BAT) were significantly (p < 0.05) lower and BAL and BAL/BAE were significantly higher among CBZ and PHT groups than among NC and LTG groups. LTG did not differ from NC in any of these measures. BAT correlated significantly with BAL/BAE for PHT (r = 0.44, p = 0.02) and CBZ (r = 0.42, p = 0.03) but not for NC (r = 0.03, p = NS) and LTG (r = 0.06, p = NS) groups.
CONCLUSIONS: In comparison to LTG, enzyme inducing AEDs (CBZ, PHT) are associated with a more favorable neuroactive steroid balance (lower DHEAS and higher BAL/BAE) for seizure management, but at the expense of reduced serum bioavailable testosterone levels and sexual function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116037     DOI: 10.1111/j.1528-1167.2006.00826.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Management of newly diagnosed epilepsy: a practical guide to monotherapy.

Authors:  Michael A Stein; Andres M Kanner
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  The far-reaching influence of hepatic enzyme-inducing antiepileptic drugs.

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2009 Nov-Dec       Impact factor: 7.500

3.  The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors.

Authors:  Doodipala Samba Reddy; Kuihuan Jian
Journal:  J Pharmacol Exp Ther       Date:  2010-06-15       Impact factor: 4.030

4.  Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroids.

Authors:  Doodipala S Reddy
Journal:  Neurochem Int       Date:  2007-06-13       Impact factor: 3.921

5.  Hormonal therapies: progesterone.

Authors:  Andrew G Herzog
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 6.  Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor.

Authors:  Cheryl A Frye; Carolyn J Koonce; Alicia A Walf
Journal:  Front Cell Neurosci       Date:  2014-04-09       Impact factor: 5.505

Review 7.  Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review.

Authors:  Mirabela Romanescu; Valentina Buda; Adelina Lombrea; Minodora Andor; Ionut Ledeti; Maria Suciu; Corina Danciu; Cristina Adriana Dehelean; Liana Dehelean
Journal:  J Pers Med       Date:  2022-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.